Skip to main content
TipRanks
Go Ultimate75% OFF

Godavari Biorefineries Limited (GODAVARIB) AI Stock Analysis

2 Followers
IN:GODAVARIB

Godavari Biorefineries Limited

(NSE:GODAVARIB)

Select Model
Rating:59Neutral
Price Target:INR 238.00▲(5.61% Upside)
Action:reiterated
Date:10/24/26

Score driven mainly by solid financial recovery via revenue surge and profit turnaround, offset by weak technical momentum and extreme overvaluation on P/E.

Positive Factors
Integrated biorefinery modelThe integrated biorefinery model creates multiple revenue streams from renewable sugarcane feedstocks, including higher-value chemicals, ethanol and co-products. This diversification can improve feedstock utilization, support customer reach across several end markets, and provide a durable platform for shifting toward specialty products.
Negative Factors
Persistent negative free cash flowFree cash flow has remained negative for two consecutive years despite improved operating cash flow, showing that investment requirements continue to exceed internally generated cash. Persistent cash consumption can constrain expansion, increase funding dependence, and reduce flexibility if operating conditions or profitability weaken.

Godavari Biorefineries Limited (GODAVARIB) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%IN:GODAVARIB-13.56%INDA-5.62%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 11.78B
Dividend Yield
―
Average Volume (3M)
23.35K
Price to Earnings (P/E)
43.7
Beta (1Y)
1.10
Revenue Growth
7.05%
EPS Growth
26.42%
Country
India
Employees
1,729
Sector
General
Sector Strength
55
Industry
Chemicals

Godavari Biorefineries Limited Business Overview & Revenue Model

Company Description

Godavari Biorefineries Limited, an Indian company established in Mumbai in 1939, specializes in the production and sale of sugar and a wide array of bio-based products. Its sugar offerings encompass classic, brown, plantation white, and refined varie...

How the Company Makes Money

Godavari Biorefineries makes money by converting sugarcane-based feedstocks into a portfolio of saleable products and selling them to industrial and consumer-ingredient customers. Key revenue streams include: (1) Bio-based specialty chemicals/ingredi...

Godavari Biorefineries Limited Financial Statement Overview

Summary

Strong revenue growth nearly 97% and turnaround to profit in income statement, stable balance sheet with manageable debt, offset by negative free cash flow from high capex.

Income Statement

85Very Positive

Balance Sheet

70Positive

Cash Flow

60Neutral
Financial statement breakdown
BreakdownTTMMar 2025Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue20.13B18.70B19.88B16.87B20.15B17.02B
Gross Profit4.12B3.14B3.72B3.31B3.79B3.23B
EBITDA1.02B1.12B1.08B1.43B1.48B1.34B
Net Income2.25M-234.15M35.28M122.98M196.37M190.97M
Balance Sheet
Total Assets019.55B20.52B19.92B17.44B17.34B
Cash, Cash Equivalents and Short-Term Investments321.53M122.51M321.53M111.12M212.73M100.25M
Total Debt04.90B5.31B6.55B7.36B6.36B
Total Liabilities-7.88B11.73B12.64B14.91B12.54B12.61B
Stockholders Equity7.88B7.82B7.88B5.01B4.89B4.73B
Cash Flow
Free Cash Flow238.17M-654.94M-446.91M1.30B-203.70M-55.30M
Operating Cash Flow936.34M61.52M1.24B1.85B1.97B448.60M
Investing Cash Flow-663.53M-687.56M-1.66B-439.93M-2.14B-476.72M
Financing Cash Flow-257.29M637.43M444.35M-1.51B284.26M59.50M

Godavari Biorefineries Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price225.35

Price Trends

50DMA228.82Negative
100DMA247.04Negative
200DMA269.95Negative

Market Momentum

MACD-1.67Negative
RSI53.85Neutral
STOCH63.75Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GODAVARIB, the sentiment is Positive. The current price of 225.35 is above the 20-day moving average (MA) of 219.21, below the 50-day MA of 228.82, and below the 200-day MA of 269.95, indicating a neutral trend. The MACD of -1.67 indicates Negative momentum. The RSI at 53.85 is Neutral, neither overbought nor oversold. The STOCH value of 63.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:GODAVARIB.

Godavari Biorefineries Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:GODAVARIB against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GULPOLYIN:GULPOLY74OutperformINR 10.27B7.16―0.88%9.30%425.35%
IN:ANDHRSUGARIN:ANDHRSUGAR66NeutralINR 11.09B10.55―1.22%16.54%204.63%
IN:GODAVARIBIN:GODAVARIB59NeutralINR 11.52B43.72――7.05%26.42%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:GEMAROMAIN:GEMAROMA55NeutralINR 7.40B-39.39――-17.65%-147.22%
IN:SANSTARIN:SANSTAR55NeutralINR 18.65B34.81――4.81%142.11%
IN:DEEPAKNTRIN:DEEPAKNTR54NeutralINR 210.17B20.40―0.47%25.13%99.89%

* General Sector Average

Performance Comparison

-20%0%20%40%IN:GODAVARIBIN:ANDHRSUGARIN:DEEPAKNTRIN:GULPOLYIN:SANSTARIN:GEMAROMADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:GODAVARIB and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:GODAVARIBGodavari Biorefineries Limited225.35-35.75-13.69%
IN:ANDHRSUGARAndhra Sugars Limited80.420.500.62%
IN:DEEPAKNTRDeepak Nitrite Limited1625.35-107.24-6.19%
IN:GULPOLYGulshan Polyols Limited173.3525.1616.98%
IN:SANSTARSanstar Limited98.956.987.59%
IN:GEMAROMAGem Aromatics Limited147.75-39.80-21.22%

Godavari Biorefineries Limited Corporate Events

Godavari Biorefineries Wins Mexican Patent for Antiviral Treatment Compounds

Oct 2, 2026

Godavari Biorefineries Limited has secured a patent from the Mexican Patent Office for its invention titled “USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS.” The patent covers compounds that inhibit V-ATPase activity in cells and their application in...

Godavari Biorefineries faces Rs. 18 crore GST demand after Karnataka tax show cause notice

Aug 29, 2026

Godavari Biorefineries Limited has disclosed that it received a show cause notice from the Office of the Commercial Tax Officer (Enforcement), DGSTO, Jamkhandi, Karnataka, concerning alleged short payment, non-payment and ineligible input tax credit...

Godavari Biorefineries Faces ₹17 Crore GST Demand Over ENA Supplies

Aug 21, 2026

Godavari Biorefineries Limited has disclosed that it received a show cause notice from the Assistant Commissioner of Central GST, Audit, Belagavi, Karnataka, alleging non-payment of GST on the supply of extra neutral alcohol (ENA) for the period from...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 24, 2026